Atara Biotherapeutics Inc (ATRA)
14.38
+2.71
(+23.22%)
USD |
NASDAQ |
Nov 13, 16:00
14.33
-0.05
(-0.35%)
After-Hours: 20:00
Atara Biotherapeutics Market Cap: 81.59M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 81.59M |
| November 12, 2024 | 66.21M |
| November 11, 2024 | 66.78M |
| November 08, 2024 | 64.17M |
| November 07, 2024 | 57.31M |
| November 06, 2024 | 56.77M |
| November 05, 2024 | 58.33M |
| November 04, 2024 | 65.99M |
| November 01, 2024 | 55.09M |
| October 31, 2024 | 50.55M |
| October 30, 2024 | 54.36M |
| October 29, 2024 | 50.33M |
| October 28, 2024 | 50.10M |
| October 25, 2024 | 48.80M |
| October 24, 2024 | 48.00M |
| October 23, 2024 | 48.06M |
| October 22, 2024 | 51.35M |
| October 21, 2024 | 52.60M |
| October 18, 2024 | 53.39M |
| October 17, 2024 | 53.22M |
| October 16, 2024 | 52.20M |
| October 15, 2024 | 47.55M |
| October 14, 2024 | 46.24M |
| October 11, 2024 | 45.56M |
| October 10, 2024 | 44.14M |
| Date | Value |
|---|---|
| October 09, 2024 | 44.31M |
| October 08, 2024 | 44.48M |
| October 07, 2024 | 43.80M |
| October 04, 2024 | 43.63M |
| October 03, 2024 | 40.85M |
| October 02, 2024 | 43.18M |
| October 01, 2024 | 43.29M |
| September 30, 2024 | 46.13M |
| September 27, 2024 | 45.82M |
| September 26, 2024 | 43.46M |
| September 25, 2024 | 41.99M |
| September 24, 2024 | 42.84M |
| September 23, 2024 | 41.76M |
| September 20, 2024 | 44.20M |
| September 19, 2024 | 44.99M |
| September 18, 2024 | 44.65M |
| September 17, 2024 | 48.28M |
| September 16, 2024 | 48.80M |
| September 13, 2024 | 55.15M |
| September 12, 2024 | 45.85M |
| September 11, 2024 | 47.15M |
| September 10, 2024 | 48.74M |
| September 09, 2024 | 50.89M |
| September 06, 2024 | 53.73M |
| September 05, 2024 | 56.74M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.42M
Minimum
Nov 10 2023
2.043B
Maximum
Dec 07 2020
667.82M
Average
502.22M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.481M |
| Palatin Technologies Inc | 23.26M |
| iBio Inc | 20.04M |
| Theriva Biologics Inc | 1.427M |
| Oragenics Inc | 1.897M |
Market Cap Related Metrics
| PS Ratio | 1.173 |
| Price | 14.38 |
| Earnings Yield | -273.6% |